Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension

被引:0
作者
Andreas Yiangou
James L. Mitchell
Vivek Vijay
Olivia Grech
Edward Bilton
Gareth G. Lavery
Claire Fisher
Julie Edwards
Susan P. Mollan
Alexandra J. Sinclair
机构
[1] University of Birmingham,Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences
[2] Diabetes and Metabolism,Centre for Endocrinology
[3] Birmingham Health Partners,Department of Neurology
[4] University Hospitals Birmingham NHS Foundation Trust,Birmingham Neuro
[5] University Hospitals Birmingham NHS Foundation Trust,Ophthalmology, Ophthalmology Department
来源
The Journal of Headache and Pain | 2020年 / 21卷
关键词
CGRP monoclonal antibody; Headache; Idiopathic intracranial hypertension; Papilloedema; Raised intracranial pressure;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 64 条
[1]  
Mollan SP(2018)Idiopathic intracranial hypertension: consensus guidelines on management J Neurol Neurosurg Psychiatry 89 1088-1100
[2]  
Davies B(2019)The expanding burden of idiopathic intracranial hypertension Eye (Lond) 33 478-485
[3]  
Silver NC(2015)Headache determines quality of life in idiopathic intracranial hypertension J Headache Pain 16 521-98
[4]  
Shaw S(2019)Advances in the understanding of headache in idiopathic intracranial hypertension Curr Opin Neurol 32 92-1165
[5]  
Mallucci CL(2019)What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals BMJ Open 9 e026573-832
[6]  
Wakerley BR(2013)Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children Neurology 81 1159-434
[7]  
Krishnan A(2018)European headache federation guideline on idiopathic intracranial hypertension J Headache Pain 19 93-808
[8]  
Chavda SV(2018)Guidelines of the international headache society for controlled trials of preventive treatment of chronic migraine in adults Cephalalgia 38 815-1464
[9]  
Ramalingam S(2017)Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial Lancet Neurol 16 425-undefined
[10]  
Edwards J(2013)The international classification of headache disorders, 3rd edition (beta version) Cephalalgia 33 629-undefined